Obesity can be deadly for people living with it, but we have potential treatments that can lead to weight loss and ...

In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the ...

Oh dear, Keir. In late October, I issued a 100-day appeal for the gloomsters and doomsters to pipe down and just let the new ...

The researchers emphasized ... Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three ...

Most people who lose weight through dieting will see it creep back up, leading to a cycle of "yo-yo dieting" that's hard on ...

Eli Lilly and Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief ...

BioAge Labs’ stock lost more than two-thirds of its market cap in pre-market trading Monday, poised to hit an all-time low ...

After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...

More than half of the world’s population may be overweight or have obesity by 2035, and slowing this trend with weight loss drugs could have enormous impacts on public health. But while ...

Fatty liver disease may contribute to fragmented sleep patterns, robbing already sick people of good rest, a new study finds.

Shares of BioAge Labs plunged nearly 70% in premarket trading Monday after the clinical-stage biopharmaceutical company said it was ending a mid-stage study of its lead program, a proposed obesity ...

Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.